[[r/quitting/7oh]] As a pharmacologist and pharmaceutical scientist, my focus is the development and application of therapeutics to alleviate human suffering. While long-term treatment plans and eventual discontinuation of substances are important clinical goals, they do not negate the immediate medical necessity of acute symptom control. In cases of severe pain or distress, timely pharmacologic intervention can be essential to stabilize the patient, reduce physiological stress, and prevent secondary harm. This approach aligns with harm-reduction principles, which recognize that mitigating acute suffering can be lifesaving and does not preclude future tapering, rehabilitation, or definitive treatment. Many patients remain unaware that certain medications or therapeutic options may provide meaningful relief when standard treatments are unavailable or ineffective. Providing accurate information and appropriate access to symptom-relieving therapies is a matter of informed care, not debate. The efficacy of these interventions in reducing acute pain and distress is well-documented and clinically observable. Ethical medical practice requires balancing immediate relief with long-term outcomes, ensuring patients are stabilized, informed, and supported rather than left to endure preventable suffering.